A detailed history of First Manhattan CO transactions in Illumina, Inc. stock. As of the latest transaction made, First Manhattan CO holds 1,802 shares of ILMN stock, worth $257,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,802
Holding current value
$257,595
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $189,714 - $244,891
1,802 New
1,802 $234,000
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $229,786 - $264,812
1,799 Added 1746.6%
1,902 $261,000
Q4 2023

Feb 13, 2024

SELL
$92.79 - $142.53 $4,732 - $7,269
-51 Reduced 33.12%
103 $14,000
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $6,603 - $8,376
36 Added 30.51%
154 $28,000
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $345,650 - $414,869
-1,784 Reduced 93.8%
118 $27,000
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $14,635 - $18,548
50 Added 2.7%
1,902 $703,000
Q2 2020

Aug 14, 2020

SELL
$256.46 - $373.01 $15,387 - $22,380
-60 Reduced 3.14%
1,852 $685,000
Q4 2019

Feb 13, 2020

SELL
$288.29 - $335.49 $1,441 - $1,677
-5 Reduced 0.26%
1,912 $634,000
Q3 2019

Nov 13, 2019

SELL
$266.84 - $378.23 $279,381 - $396,006
-1,047 Reduced 35.32%
1,917 $583,000
Q2 2019

Aug 16, 2019

SELL
$300.59 - $368.15 $150,295 - $184,075
-500 Reduced 14.43%
2,964 $1.09 Million
Q1 2019

Apr 12, 2019

BUY
$272.57 - $321.18 $149,095 - $175,685
547 Added 18.75%
3,464 $1.08 Million
Q4 2018

Jan 30, 2019

BUY
$272.46 - $366.54 $272,460 - $366,540
1,000 Added 52.16%
2,917 $874,000
Q3 2018

Oct 15, 2018

SELL
$279.04 - $367.06 $1,395 - $1,835
-5 Reduced 0.26%
1,917 $703,000
Q2 2018

Aug 01, 2018

BUY
$228.17 - $292.07 $11,408 - $14,603
50 Added 2.67%
1,922 $536,000
Q3 2017

Oct 25, 2017

BUY
$172.3 - $213.93 $322,545 - $400,476
1,872
1,872 $372,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.